基本信息
浏览量:412
职业迁徙
个人简介
A major focus of his laboratory is new drug development, for which his Center has received NIH funding. Within the Center is a dedicated phase I facility, where first-in-human and early phase studies are conducted. His Center has worked closely with private industry to develop new antiplatelet agents, and has played a pivotal role in the development of two recently approved antiplatelet agents (prasugrel and ticagrelor) indicated for the treatment of ACS. Dr. Gurbel's current research is focused on further understanding how genotype and various aspects of platelet function should be used to optimally identify the patient with high cardiovascular risk.
研究兴趣
论文共 954 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Kevin Bliden,Sahib Singh, Roni Shanoada,Isha Kalia,Udaya Tantry, Alyssa Zimmerman, Aravind Dilli Babu, Lekshminarayan Raghavakurup, Taylor Stude, Damian Sidorski,Paul Gurbel
Journal of Translational Genetics and Genomicsno. 2 (2024): 186-206
Paul A. Gurbel,Kevin Bliden,Matthew Sherwood,Hamid Taheri,Behnam Tehrani, Marjaneh Akbari,Shahram Yazdani, Juzer Ali Asgar,Rahul Chaudhary,Udaya S. Tantry
Journal of Thrombosis and Thrombolysispp.1-10, (2024)
AMERICAN JOURNAL OF CARDIOLOGY (2024): 126-131
Kevin P. Bliden,Parshotam Kundan,Danielle Kraft, Rueshil Parekh,Sahib Singh, Aravind D. Babu, Anika P. Shah,Udaya S. Tantry,Paul A. Gurbel
Plateletsno. 1 (2024): 2298352-2298352
The American journal of cardiology (2024): 24-31
Paul A. Gurbel,Kevin Bliden, Swecha Goel, Taylor Stude, Damian Sidorski, Lekshmi Narayan Raghavakurup,Sahib Singh, Syed Muhammad Murtaza Ishaq,Udaya Tantry
Journal of the American College of Cardiologyno. 13 (2024): 1044
CURRENT PROBLEMS IN CARDIOLOGYno. 3 (2024): 102403-102403
EUROINTERVENTIONno. 16 (2023): E1304-E1306
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn